CLINICAL USE


Antibiotic:Anaerobic and protozoal infections

DOSE IN NORMAL RENAL FUNCTION

Oral: 200–500 mg every 8–12 hoursIV: 500 mg every 8 hoursPR: 1 g every 8–12 hours

PHARMACOKINETICS

  • Molecular weight &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :171.2
  • %Protein binding &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :
  • 10 to 20 &nbsp &nbsp :
  • %Excreted unchanged in urine &nbsp &nbsp : 20
  • Volume of distribution (L/kg) &nbsp &nbsp &nbsp :0.7–1.5
  • half-life – normal/ESRD (hrs)&nbsp &nbsp &nbsp :5.6–11.4/7–21

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50 &nbsp &nbsp : Dose as in normal renal function
  • 10 to 20 &nbsp &nbsp : Dose as in normal renal function
  • <10 &nbsp &nbsp &nbsp &nbsp &nbsp : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp:Not dialysed. Dose as in normal renal function

  • HD &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp &nbsp :Dialysed. Dose as in normal renal function
  • HDF/high flux &nbsp :Dialysed. Dose as in normal renal function
  • CAV/VVHD &nbsp &nbsp &nbsp:Unknown dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Alcohol: disulfiram-like reaction
  • Anticoagulants: effects of coumarins enhanced
  • Anti-epileptics: metabolism of phenytoin inhibited; concentration reduced by primidone and barbiturates
  • Ciclosporin: raised blood level of ciclosporinCytotoxics: busulfan concentration increased; metabolism of fluorouracil inhibited

    ADMINISTRATION

    Reconstition

    Route

    IV, oral, PR

    Rate of Administration

    IV: 5 mL/minute, i.e. 500 mg over 20 minutes

    Comments

    OTHER INFORMATION

    Active metabolites have long half-life in renal impairmentIncreased incidence of GIT reactions and vestibular toxicity in renal failureDrug induced lupus is a rare adverse drug reactionRectally: dose frequency reduced to 12 hours after 3 days500 mg /100 mL infusion provides 14 mmol sodium.